NO862390L - Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.Info
- Publication number
- NO862390L NO862390L NO862390A NO862390A NO862390L NO 862390 L NO862390 L NO 862390L NO 862390 A NO862390 A NO 862390A NO 862390 A NO862390 A NO 862390A NO 862390 L NO862390 L NO 862390L
- Authority
- NO
- Norway
- Prior art keywords
- methyl
- carbon atoms
- phenyl
- cyano
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74596585A | 1985-06-17 | 1985-06-17 | |
| US85273186A | 1986-04-21 | 1986-04-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO862390D0 NO862390D0 (no) | 1986-06-16 |
| NO862390L true NO862390L (no) | 1986-12-18 |
Family
ID=27114542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862390A NO862390L (no) | 1985-06-17 | 1986-06-16 | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0206747B1 (da) |
| KR (1) | KR900005024B1 (da) |
| AU (1) | AU601946B2 (da) |
| CA (1) | CA1267416A (da) |
| DE (1) | DE3675271D1 (da) |
| DK (1) | DK281186A (da) |
| ES (1) | ES8800904A1 (da) |
| FI (1) | FI862343A7 (da) |
| GR (1) | GR861529B (da) |
| NO (1) | NO862390L (da) |
| NZ (1) | NZ216555A (da) |
| PT (1) | PT82766A (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601382D0 (en) * | 1986-01-21 | 1986-02-26 | Pfizer Ltd | Dihydropyridine antiischaemic & antihypertensive agents |
| GB8526411D0 (en) * | 1985-10-25 | 1985-11-27 | Pfizer Ltd | Dihydropyridines |
| IT1197012B (it) * | 1986-07-29 | 1988-11-25 | Boehringer Biochemia Srl | 2-(aciltio) metil diidropiridine, un processo per la loro preparazione e composizioni farmaceutiche che le contengono |
| IT1213555B (it) * | 1986-12-11 | 1989-12-20 | Boehringer Biochemia Srl | 2 metiltiometildiidropiridine, un processo per laloro preparazione e composizioni farmaceutiche che le contengono. |
| IT1215381B (it) * | 1987-03-12 | 1990-02-08 | Boehringer Biochemia Srl | Farmaceutiche che le contengono. carbonil- e solfonil- derivati di 2-(aminoalchiltio)metil-1,4-diidropiridine, un metodo per la loro preparazione e composizioni |
| DE3732380A1 (de) * | 1987-09-25 | 1989-04-06 | Bayer Ag | Dihydropyridinether, verfahren zu ihrer herstellung und ihre verwendung |
| SE8705150D0 (sv) * | 1987-12-23 | 1987-12-23 | Haessle Ab | Novel antiarrhythmic agents |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2239815C2 (de) | 1972-08-12 | 1983-02-10 | Bayer Ag, 5090 Leverkusen | 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel |
| DE2242786A1 (de) | 1972-08-31 | 1974-03-14 | Bayer Ag | Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel |
| DE2248150A1 (de) | 1972-09-30 | 1974-04-04 | Bayer Ag | Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2335466A1 (de) | 1973-07-12 | 1975-01-30 | Bayer Ag | Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| BE843576A (fr) | 1975-04-03 | 1976-12-29 | Derives de 1,4-dihydropyridine et leur procede de preparation | |
| GB1591089A (en) | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
| DE2658183A1 (de) | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
| DE3130041A1 (de) | 1981-07-30 | 1983-02-17 | Bayer Ag, 5090 Leverkusen | Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung |
| DE3239273A1 (de) | 1982-10-23 | 1984-04-26 | Bayer Ag, 5090 Leverkusen | Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| EP0125803A3 (en) * | 1983-04-27 | 1987-01-21 | FISONS plc | Pharmaceutically active dihydropyridines |
| GR851819B (da) * | 1984-08-17 | 1985-11-26 | Wyeth John & Brother Ltd | |
| EP0200524A3 (en) | 1985-05-03 | 1987-06-16 | Pfizer Limited | Dihydropyridine calcium antagonists |
-
1986
- 1986-06-02 CA CA000510582A patent/CA1267416A/en not_active Expired - Fee Related
- 1986-06-02 FI FI862343A patent/FI862343A7/fi not_active Application Discontinuation
- 1986-06-04 AU AU58428/86A patent/AU601946B2/en not_active Expired - Fee Related
- 1986-06-12 GR GR861529A patent/GR861529B/el unknown
- 1986-06-16 ES ES556082A patent/ES8800904A1/es not_active Expired
- 1986-06-16 KR KR1019860004759A patent/KR900005024B1/ko not_active Expired
- 1986-06-16 DK DK281186A patent/DK281186A/da not_active Application Discontinuation
- 1986-06-16 NO NO862390A patent/NO862390L/no unknown
- 1986-06-16 NZ NZ216555A patent/NZ216555A/xx unknown
- 1986-06-16 PT PT82766A patent/PT82766A/pt unknown
- 1986-06-17 DE DE8686304679T patent/DE3675271D1/de not_active Expired - Fee Related
- 1986-06-17 EP EP86304679A patent/EP0206747B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK281186D0 (da) | 1986-06-16 |
| EP0206747B1 (en) | 1990-10-31 |
| PT82766A (en) | 1986-07-01 |
| DK281186A (da) | 1986-12-18 |
| KR900005024B1 (ko) | 1990-07-18 |
| KR870000298A (ko) | 1987-02-17 |
| FI862343A7 (fi) | 1986-12-18 |
| NO862390D0 (no) | 1986-06-16 |
| AU5842886A (en) | 1986-12-24 |
| ES556082A0 (es) | 1987-12-01 |
| GR861529B (en) | 1986-10-14 |
| FI862343A0 (fi) | 1986-06-02 |
| EP0206747A3 (en) | 1987-08-19 |
| NZ216555A (en) | 1989-01-06 |
| CA1267416A (en) | 1990-04-03 |
| EP0206747A2 (en) | 1986-12-30 |
| AU601946B2 (en) | 1990-09-27 |
| DE3675271D1 (de) | 1990-12-06 |
| ES8800904A1 (es) | 1987-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6861858B2 (ja) | Ｓｓａｏ阻害剤 | |
| KR100191416B1 (ko) | 4-아미노퀴나졸린 유도체, 그의 제조 방법, 그를 포함하는 제약학적 조성물 및 그의 사용 | |
| KR0170567B1 (ko) | 부신피질자극호르몬-유리 인자 길항물질 활성을 갖는 피라졸 및 피라졸로피리미딘 | |
| AU2002350315B2 (en) | Quinolinones as prostaglandin receptor ligands | |
| US6005109A (en) | Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity | |
| JPH0789958A (ja) | ４−アミノピリミジン誘導体、その製造方法およびそれを含有する医薬品 | |
| NO861897L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| JP2006504738A (ja) | Ｌ型カルシウムチャンネルを遮断し、かつホスホジエステラーゼ３型活性を阻害する同時能力を有するジヒドロピリジン化合物 | |
| JP2019526577A (ja) | イミダゾール誘導体及び自己免疫性疾患若しくは炎症性疾患又は癌の治療におけるそれらの使用 | |
| PL140573B1 (en) | Method of obtaining new dihydropyridine derivatives | |
| DE3522579C2 (de) | Neue 1,4-Dihydropyridin-Derivate und Salze derselben, Verfahren zur Herstellung derselben und pharmazeutische Mittel mit einem Gehalt derselben | |
| IE47481B1 (en) | 1-piperidinophthalazine cardiac stimulants | |
| NO862390L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater. | |
| CZ20032145A3 (cs) | 4-Aminobenzopyranové deriváty | |
| US5576327A (en) | Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds | |
| EP0257616B1 (en) | Dihydropyridine derivates and pharmaceutical composition thereof | |
| US4820842A (en) | 2-substituted-1,4-dihydropyridines | |
| US4723014A (en) | Process for the preparation of 2-substituted-1,4-dihydropyridines | |
| KR880000131B1 (ko) | 디하이드로피리딘의 제조방법 | |
| CN110770209B (zh) | 用作p2x1及p2x3受体拮抗剂的新型5-羟基吡啶类化合物及包含其的药物组合物 | |
| NO861756L (no) | Fremgangsmaate ved fremstilling av dihydropyridinderivater. | |
| US4886819A (en) | Dihydropyridine derivatives and pharmaceutical composition thereof | |
| JPH03173885A (ja) | ピリミジンジオン誘導体化合物、該化合物の製造法および該化合物を含む抗不整脈剤 | |
| CN111285859A (zh) | 一类以hiv-1逆转录酶为靶点的2,4,5-三取代嘧啶类化合物及其制备方法与应用 | |
| US4957930A (en) | Dihydropyridine derivatives |